EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (EDAP)
Last edap tms s.a. - american depositary shares, each representing one ordinary share earnings: 3/30 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.edap-tms.com/investor-relations
Company Research
Source: GlobeNewswire
LYON, France, October 1, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II study evaluating the Company’s proprietary Focal One® robotic high-intensity focused ultrasound (HIFU) technology for the treatment of benign prostatic hyperplasia (BPH). “We’ve been offering targeted HIFU ablation to prostate cancer patients for more than 15 years,” said Harry Toledano, MD, Head of the Urology Department of Martigues Hospital in Martigues, France. “Based on this large experience and the follow-up of hundreds of prostate cancer patients with their functional outcomes, we believe that the HIFU energy precisely delivered by Focal One has the potential to improve BPH symptoms with minimal side effects allowing a quick return to normal activities for a significant number of patients. We are enthusiastic to co-lead the first phase of this important clinical trial with our co
Show less
Read more
Impact Snapshot
Event Time:
EDAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDAP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDAP alerts
High impacting EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share news events
Weekly update
A roundup of the hottest topics
EDAP
News
- Edap Tms S.A. (NASDAQ: EDAP) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer CenterGlobeNewswire
- EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. ProceduresGlobeNewswire
- EDAP Appoints Joshua H. Levine to Board of DirectorsGlobeNewswire
- EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU TechnologyGlobeNewswire
EDAP
Earnings
- 11/7/24 - Miss
EDAP
Sec Filings
- 1/13/25 - Form 6-K
- 1/10/25 - Form 6-K
- 12/4/24 - Form 6-K
- EDAP's page on the SEC website